Long-term follow-up data reinforce the curative potential of hematopoietic stem-cell gene therapy for this rare primary immunodeficiency disorder.
References
Notarangelo, L. D., Miao, C. H. & Ochs, H. D. Curr. Opin. Hematol. 15, 30–36 (2008).
Albert, M. H., Notarangelo, L. D. & Ochs, H. D. Curr. Opin. Hematol. 18, 42–48 (2011).
Pai, S. Y. & Notarangelo, L. D. Immunol. Allergy Clin. North Am. 30, 179–194 (2010).
Burroughs, L. M. et al. Blood 135, 2094–2105 (2020).
Ferrua, F. et al. J. Allergy Clin. Immunol. 146, 262–265 (2020).
Magnani, F. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01641-x (2021).
Boztug, K. et al. N. Engl. J. Med. 363, 1918–1927 (2010).
Braun, C. J. et al. Sci. Transl. Med. 6, 227ra33 (2014).
Dupré, L. et al. Hum. Gene Ther. 17, 303–313 (2006).
Marangoni, F. et al. Mol. Ther. 17, 1073–1082 (2009).
Kohn, L. A. & Kohn, D. B. Front. Immunol. 12, 648951 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Biffi, A. Gene therapy goes the distance in Wiskott–Aldrich syndrome. Nat Med 28, 24–25 (2022). https://doi.org/10.1038/s41591-021-01653-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01653-7
- Springer Nature America, Inc.